Investor Overview

Rexahn Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to developing best-in-class therapeutics for the treatment of cancer. Rexahn currently has two clinical stage oncology candidates, RX-3117 and RX-5902 (Supinoxin™), and additional compounds in preclinical development to treat multiple types of cancer.

Shareholder Letter - August 2018

Press Releases

Date Title and Summary
Toggle Summary Rexahn Pharmaceuticals Announces Leadership Transition
Douglas Swirsky Assumes Role of Chief Executive Officer ROCKVILLE, Md. , Nov. 14, 2018 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American: RNN), a clinical stage biopharmaceutical company developing innovative therapies to improve outcomes in cancers that are difficult to treat, today
Toggle Summary Rexahn Reports Third Quarter 2018 Financial Results
ROCKVILLE, Md. , Nov. 05, 2018 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American: RNN), a clinical stage biopharmaceutical company developing innovative, targeted therapeutics for the treatment of cancer, announced financial results for the three and nine months ended September 30,
Toggle Summary Rexahn Announces $7.5 Million Registered Direct Offering
ROCKVILLE, Md. , Oct. 17, 2018 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American: RNN) today announced it has entered into definitive agreements with institutional investors to purchase approximately 5.77 million shares of its common stock and warrants exercisable for up to

Events & Presentations

Date Event Details
Summary Toggle Mar 17-20, 2013 Mar 17 - Mar 20, 2013 12:00 AM EDT 03/17/13
Summary Toggle Apr 6-10, 2013 Apr 6 - Apr 10, 2013 12:00 AM EDT 04/06/13

Title: Mechanistic study of a new 4-(3, 5-dimethoxyphenyl)-N-(7-fluoro-3-methoxyquinoxalin-2-yl)piperazine-1-carboxamide compound (RX-5902)
 [View Poster]

Summary Toggle Apr 22-25, 2013 Apr 22 - Apr 25, 2013 12:00 AM EDT 04/22/13


©2018 by Rexahn Pharmaceuticals, Inc. All rights reserved
Rexahn Pharmaceuticals, Inc. - 15245 Shady Grove Road, Suite 455 - Rockville, MD 20850

Terms of Use
Privacy Policy